Perbedaan Merck Tbk. dan Multi Indocitra Tbk.: Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb), sedangkan Multi Indocitra Tbk. diperdagangkan di Rp530 (kapitalisasi pasar 303 M, volume 24 jam 154,1 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 5,6× kapitalisasi pasar Multi Indocitra Tbk., dan Multi Indocitra Tbk. lebih aktif diperdagangkan (154,1 rb vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MERK | MICE | |
|---|---|---|
Kapitalisasi Pasar | 1,7 T | 303 M |
Volume | 37,6 rb | 154,1 rb |
Lot | 376 | 1,54 rb |
Perputaran | 144,47 jt | 81,24 jt |
Harga Rata-rata | 3.842,23 | 527,17 |
Nilai Transaksi | 144,47 jt | 81,24 jt |
Harga Ekuilibrium Indikatif | 3.840 | — |
Volume Ekuilibrium Indikatif | 7 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Selengkapnya di halaman MICE →